Immune-modulating peptides are researched for their roles in innate and adaptive immune response pathways, antimicrobial defence mechanisms, and inflammatory regulation in laboratory models.
Key compounds include Thymosin Alpha-1 (Tα1), studied for T-cell maturation and immune surveillance enhancement; LL-37, a human cathelicidin-derived antimicrobial peptide investigated for host-defence and wound-healing research; KPV, an alpha-MSH fragment explored for anti-inflammatory NF-κB pathway modulation; and Thymulin, a nonapeptide studied for thymic function and immune regulation.
Researchers also investigate BPC-157 in immune-gut axis models and Larazotide for intestinal-permeability pathway studies.
For laboratory and research use only. Not for human consumption.
